말 헬스케어 시장 예측(-2030년) : 제품 유형별, 동물 유형별, 질병 유형별, 유통 채널별, 최종사용자별, 지역별 세계 분석

According to Stratistics MRC, the Global Equine Healthcare Market is accounted for $3.6 billion in 2024 and is expected to reach $6.5 billion by 2030 growing at a CAGR of 10.3% during the forecast period. Equine healthcare is a specialized field that focuses on the health and well-being of horses through medical care, nutrition, and management practices. It includes routine veterinary care, such as vaccinations and dental exams, to prevent common diseases like colic, laminitis, and respiratory infections. Proper hoof care by farriers ensures horses' mobility and reduces lameness risk. Nutrition is a core component, with tailored diets balancing hay, grains, and supplements based on age, activity level, and health status. Exercise management is crucial for fitness, mental well-being, and injury prevention. Equine healthcare also addresses reproductive health, assisting with breeding, pregnancy, and foal care.

According to a February 2024 press release by Euro News, scientists from Costa Rica are involved in R&D to develop antidotes for human snake bites. They are utilizing the horses as the vessels to develop antibodies against the vaccine.

Market Dynamics:

Driver:

Rising incidence of equine diseases

Specialized horse healthcare services have increased as a result of the rise in equine diseases and the resulting demand for veterinary care, diagnosis, and treatments. Increased patient loads in hospitals and veterinary clinics are the main cause of this demand. Advanced diagnostic technologies are also in high demand due to the rising incidence of horse diseases and the need for precise diagnostic methods such blood tests, imaging tests, and genetic testing.

Restraint:

Limited access to veterinary care in rural areas

Rural areas lack access to veterinary services, resulting in fewer horse owners seeking regular care. This leads to a lower demand for equine healthcare products and services, limiting market penetration. Untreated diseases can also go undiagnosed or untreated, causing infections and severe conditions. Long recovery times and increased healthcare costs can be exacerbated. Therefore, timely veterinary intervention is crucial to mitigate these issues and improve the overall quality of life for horses in these areas.

Opportunity:

Heightened awareness regarding equine health among horse owners and veterinarians

Horse owners are increasingly seeking veterinary services due to increased awareness about equine health issues. This leads to a higher demand for routine check-ups, vaccinations, and specialized treatments. The market for preventive care, such as regular vaccinations and parasite control, is expected to grow as more horse owners prioritize their animals' health. This increased focus on preventive measures contributes to the growth of the market for vaccines, diagnostic tools, and other healthcare products designed to maintain equine health.

Threat:

Shortage of skilled veterinarians

As the number of practicing equine veterinarians decreases, horse owners face increasing difficulties in accessing timely veterinary care. Many clinics struggle to accommodate new clients, leading to longer wait times for appointments and emergency services. This limited access can result in untreated health issues, negatively impacting horse welfare and increasing the risk of serious health complications hampering the market growth.

Covid-19 Impact

The COVID-19 pandemic significantly accelerated the demand for service robotics across various sectors. With increased emphasis on minimizing human contact and maintaining operational continuity, robots were rapidly deployed in healthcare, logistics, and disinfection services. In warehouses and retail, robots helped fulfill heightened e-commerce demands. This surge highlighted the value of robotics for efficiency and safety, driving long-term investment and innovation in service robotics post-pandemic.

The therapeutics segment is expected to be the largest during the forecast period

The therapeutics segment is estimated to be the largest, due to the increasing adoption of anti-infective drugs, vaccines, pain relievers, and regenerative therapies. This growth is driven by increased investment in disease prevention and treatment options by horse owners and facilities. Therapeutics also plays a crucial role in disease control and prevention, supporting herd health and reducing costly outbreaks.

The lyme disease segment is expected to have the highest CAGR during the forecast period

The lyme disease segment is anticipated to witness the highest CAGR during the forecast period, because lyme disease in horses requires complex diagnostic procedures, including serological assays like ELISA and confirmatory tests like Western blot or immunofluorescence assays. Advanced diagnostic tools like the Equine Lyme Multiplex Assay improve early detection and accuracy, crucial for effective treatment. Thus market growth is driven by the need for comprehensive diagnostic services and increased awareness among horse owners about Lyme disease.

Region with largest share:

Asia Pacific is expected to have the largest market share during the forecast period because the Asia Pacific, particularly China, Japan, and Australia, is experiencing a surge in equestrian sports, leading to a growing demand for equine healthcare products. This demand is driven by the growing participation in racing, show jumping, and polo, as well as the growing importance of therapeutic solutions like vaccines, anti-infectives, and supplements to address common equine health issues.

Region with highest CAGR:

North America is projected to witness the highest CAGR over the forecast period; access to expert equine doctors, clinics, and hospitals is made possible by the strong veterinary care infrastructure in North America. By providing specialized, high-quality care, this expands the market. The rising demand for horse diseases including tetanus, equine influenza, and West Nile virus is also driving a large investment in preventive treatment, including vaccines, deworming products, and supplements.

Key players in the market

Some of the key players profiled in the Equine Healthcare Market include Arthrex Inc., Boehringer Ingelheim International GmbH, Cargill, Ceva Sante Animale, Covetrus Inc., Dechra Pharmaceuticals, Elanco, Esaote SPA, Hallmarq Veterinary Imaging, Heska Corporation, IDEXX Laboratories, Inc., Kyoritsuseiyaku Corporation, Merck & Co. Inc, Neogen Corporation, Purina Animal Nutrition LLC., Vetoquinol S.A. and Zoetis

Key Developments:

In November 2024, Merck announced that Merck has entered into an exclusive global license to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova.

In October 2024, Gilead and Merck announced Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression in Adults at Week 48.

In October 2024, Cargill launched new cocoa production line in Indonesia to meet growing Asian consumers' demand for indulgent foods. The new line brings innovation capabilities and competitiveness to customers in the bakery, ice cream and chocolate confectionery categories, as well as for the cafe-style beverages in foodservice.

Product Types Covered:

• Therapeutics
• Diagnostics
• Supplemental Nutrition
• Other Product Types

Animal Types Covered:

• Performance Horses
• Recreational Horses
• Working Horses
• Racehorses
• Other Animal Types

Disease Types Covered:

• Equine Influenza
• Lyme Disease
• Tetanus
• Rabies
• Equine Encephalomyelitis
• Musculoskeletal Disorders
• West Nile Virus
• Rabies
• Other Disease Types

Distribution Channels Covered:

• Veterinary Hospitals & Clinics
• E-Commerce
• Retail Pharmacies & Drug Stores
• Other Distribution Channels

End Users Covered:

• Veterinary Hospitals
• Animal Clinics
• Research Institutes
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Equine Healthcare Market, By Product Type

• 5.1 Introduction
• 5.2 Therapeutics
  • 5.2.1 Vaccines
  • 5.2.2 Anti-Infective Agents
  • 5.2.3 Parasiticides
  • 5.2.4 Anti-Inflammatory Drugs
• 5.3 Diagnostics
  • 5.3.1 Clinical Pathology
  • 5.3.2 Immunoassays
  • 5.3.3 Molecular Diagnostics
  • 5.3.4 Imaging Techniques
• 5.4 Supplemental Nutrition
  • 5.4.1 Feed Additives
  • 5.4.2 Performance Supplements
• 5.5 Other Product Types

6 Global Equine Healthcare Market, By Animal Type

• 6.1 Introduction
• 6.2 Performance Horses
• 6.3 Recreational Horses
• 6.4 Working Horses
• 6.5 Racehorses
• 6.6 Other Animal Types

7 Global Equine Healthcare Market, By Disease Type

• 7.1 Introduction
• 7.2 Equine Influenza
• 7.3 Lyme Disease
• 7.4 Tetanus
• 7.5 Rabies
• 7.6 Equine Encephalomyelitis
• 7.7 Musculoskeletal Disorders
• 7.8 West Nile Virus
• 7.9 Rabies
• 7.10 Other Disease Types

8 Global Equine Healthcare Market, By Distribution Channel

• 8.1 Introduction
• 8.2 Veterinary Hospitals & Clinics
• 8.3 E-Commerce
• 8.4 Retail Pharmacies & Drug Stores
• 8.5 Other Distribution Channels

9 Global Equine Healthcare Market, By End User

• 9.1 Introduction
• 9.2 Veterinary Hospitals
• 9.3 Animal Clinics
• 9.4 Research Institutes
• 9.5 Other End Users

10 Global Equine Healthcare Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Arthrex Inc.
• 12.2 Boehringer Ingelheim International GmbH
• 12.3 Cargill
• 12.4 Ceva Sante Animale
• 12.5 Covetrus Inc.
• 12.6 Dechra Pharmaceuticals
• 12.7 Elanco
• 12.8 Esaote SPA
• 12.9 Hallmarq Veterinary Imaging
• 12.10 Heska Corporation
• 12.11 IDEXX Laboratories, Inc.
• 12.12 Kyoritsuseiyaku Corporation
• 12.13 Merck & Co. Inc
• 12.14 Neogen Corporation
• 12.15 Purina Animal Nutrition LLC.
• 12.16 Vetoquinol S.A.
• 12.17 Zoetis